Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 9/2005

01-09-2005 | Original Paper

Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma

Authors: Panayiotis A Kyzas, Dimitrios Stefanou, Anna Batistatou, Niki J Agnantis

Published in: Journal of Cancer Research and Clinical Oncology | Issue 9/2005

Login to get access

Abstract

Purpose: Tumor angiogenesis is crucial for both the growth of the primary tumor and the development of metastases. Among the factors causing tumor angiogenesis, vascular endothelial growth factor (VEGF) is considered as a leading candidate. We aimed to assess the prognostic significance of VEGF and tumor angiogenesis in head and neck squamous cell carcinoma (HNSCC). Methods: We performed a retrospective study of 69 patients with HNSCC, in order to investigate whether VEGF immunohistochemical expression and tumor angiogenesis correlate with clinicopathological parameters and outcome. Tumor angiogenesis was estimated by determining microvessel density (MVD), and VEGF expression was assessed quantitatively. Results: Vascular endothelial growth factor and MVD correlated statistically significant with the clinical stage, but not with the presence of lymph node metastasis at the time of diagnosis. Tumors located in the oral cavity and larynx more often expressed high VEGF immunostaining compared with tumors located in the lower lip. High VEGF expression was associated with higher clinical stage and worse overall survival in this cohort of patients. Conclusions: Vascular endothelial growth factor expression may have prognostic significance for patients with HNSCC.
Literature
go back to reference Aebersold DM, Beer KT, Laissue J, Hug S, Kollar A, Greiner RH, Djonov V (2000) Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx. Int J Radiat Oncol Biol Phys 48:17–25CrossRefPubMed Aebersold DM, Beer KT, Laissue J, Hug S, Kollar A, Greiner RH, Djonov V (2000) Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx. Int J Radiat Oncol Biol Phys 48:17–25CrossRefPubMed
go back to reference Ahlgren J, Risberg B, Villman K, Bergh J (2002) Angiogenesis in invasive breast carcinoma—a prospective study of tumour heterogeneity. Eur J Cancer 38:64–69CrossRefPubMed Ahlgren J, Risberg B, Villman K, Bergh J (2002) Angiogenesis in invasive breast carcinoma—a prospective study of tumour heterogeneity. Eur J Cancer 38:64–69CrossRefPubMed
go back to reference Altman DG, Lausen B, Sauerbrei W, Schumacher M (1994) Dangers of using “optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86:829–835PubMedCrossRef Altman DG, Lausen B, Sauerbrei W, Schumacher M (1994) Dangers of using “optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86:829–835PubMedCrossRef
go back to reference Artese L, Rubini C, Ferrero G, Fiorini M, Santinelli A, Piatelli A (2001) Microvessel density (MVD) and vascular endothelial growth factor expression (VEGF) in human oral squamous cell carcinoma. Anticancer Res 21:689–696PubMed Artese L, Rubini C, Ferrero G, Fiorini M, Santinelli A, Piatelli A (2001) Microvessel density (MVD) and vascular endothelial growth factor expression (VEGF) in human oral squamous cell carcinoma. Anticancer Res 21:689–696PubMed
go back to reference Breslin JW, Pappas PJ, Cerveira JJ, Hobson RW, Duran WN (2003) VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am J Physiol Heart Circ Physiol 284:92–100 Breslin JW, Pappas PJ, Cerveira JJ, Hobson RW, Duran WN (2003) VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am J Physiol Heart Circ Physiol 284:92–100
go back to reference Concato J, Feinstein AR, Holford TR (1993) The risk of determining risk with multivariable models. Ann Intern Med 118:201–210PubMed Concato J, Feinstein AR, Holford TR (1993) The risk of determining risk with multivariable models. Ann Intern Med 118:201–210PubMed
go back to reference Dray TG, Hardin NJ, Sofferman RA (1995) Angiogenesis as a prognostic marker in early head and neck cancer. Ann Otol Rhinol Laryngol 104:724–729PubMed Dray TG, Hardin NJ, Sofferman RA (1995) Angiogenesis as a prognostic marker in early head and neck cancer. Ann Otol Rhinol Laryngol 104:724–729PubMed
go back to reference Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17:984–992CrossRefPubMed Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17:984–992CrossRefPubMed
go back to reference Dunphy F, Stack BC Jr, Boyd JH, Dunleavy TL, Kim HJ, Dunphy CH (2002) Microvessel density in advanced head and neck squamous cell carcinoma before and after chemotherapy. Anticancer Res 22:1755–1758PubMed Dunphy F, Stack BC Jr, Boyd JH, Dunleavy TL, Kim HJ, Dunphy CH (2002) Microvessel density in advanced head and neck squamous cell carcinoma before and after chemotherapy. Anticancer Res 22:1755–1758PubMed
go back to reference Ellis LM, Liu W, Fan F, Reinmuth N, Shaheen RM, Jung YD, Ahmad S (2001) Role of angiogenesis inhibitors in cancer treatment (Huntingt). Oncology 15:39–46PubMed Ellis LM, Liu W, Fan F, Reinmuth N, Shaheen RM, Jung YD, Ahmad S (2001) Role of angiogenesis inhibitors in cancer treatment (Huntingt). Oncology 15:39–46PubMed
go back to reference Ferrara N, Davis-Smith T (1997) The biology of vascular endothelial growth factor. Endocrin Rev 18:4–25CrossRef Ferrara N, Davis-Smith T (1997) The biology of vascular endothelial growth factor. Endocrin Rev 18:4–25CrossRef
go back to reference Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM (2000) Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:966–978PubMed Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM (2000) Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:966–978PubMed
go back to reference Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–6PubMedCrossRef Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–6PubMedCrossRef
go back to reference Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V, Chiarugi V, Masini E (2001) Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer: implications for tumor angiogenesis and metastasis. Neoplasia 3:53–61CrossRefPubMed Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V, Chiarugi V, Masini E (2001) Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer: implications for tumor angiogenesis and metastasis. Neoplasia 3:53–61CrossRefPubMed
go back to reference Gallo O, Massini E, Bianchi B, Bruschini L, Paglierani M, Franchi A (2002) Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol 33:708–714CrossRefPubMed Gallo O, Massini E, Bianchi B, Bruschini L, Paglierani M, Franchi A (2002) Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol 33:708–714CrossRefPubMed
go back to reference Gleich LL, Biddinger PW, Pavelic ZP, Gluckman JL (1996) Tumor angiogenesis in T1 oral cavity squamous cell carcinoma: role in predicting tumor aggressiveness. Head Neck 18:343–346CrossRefPubMed Gleich LL, Biddinger PW, Pavelic ZP, Gluckman JL (1996) Tumor angiogenesis in T1 oral cavity squamous cell carcinoma: role in predicting tumor aggressiveness. Head Neck 18:343–346CrossRefPubMed
go back to reference Gupta K, Kshirsagar S, Li W, Gui L, Ramakrishnan S, Gupta P, Law PY, Hebbel RP (1999) VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signalling. Exp Cell Res 247:495–504CrossRefPubMed Gupta K, Kshirsagar S, Li W, Gui L, Ramakrishnan S, Gupta P, Law PY, Hebbel RP (1999) VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signalling. Exp Cell Res 247:495–504CrossRefPubMed
go back to reference Hannen EJ, van der Laak JA, Manni JJ, Freihofer HP, Slootweg PJ, Koole R, de Wilde PC (2002) Computer assisted analysis of the microvasculature in metastasized and nonmetastasized squamous cell carcinomas of the tongue. Head Neck 24:643–650CrossRefPubMed Hannen EJ, van der Laak JA, Manni JJ, Freihofer HP, Slootweg PJ, Koole R, de Wilde PC (2002) Computer assisted analysis of the microvasculature in metastasized and nonmetastasized squamous cell carcinomas of the tongue. Head Neck 24:643–650CrossRefPubMed
go back to reference Homer JJ, Prentice MG, Cawkwell L, Birchall M, Greemman J, Stafford ND (2003) Angiogenesis and expression of vascular endothelial growth factors A and C in squamous cell carcinoma of the piriform fossa. Arch Otolaryngol Head Neck Surg 129:1110–1114CrossRefPubMed Homer JJ, Prentice MG, Cawkwell L, Birchall M, Greemman J, Stafford ND (2003) Angiogenesis and expression of vascular endothelial growth factors A and C in squamous cell carcinoma of the piriform fossa. Arch Otolaryngol Head Neck Surg 129:1110–1114CrossRefPubMed
go back to reference Ikeda N, Adachi M, Taki T, Huang C, Hashida H, Takabayashi A, Sho M, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H, Miyake M (1999) Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 79:1553–1563CrossRefPubMed Ikeda N, Adachi M, Taki T, Huang C, Hashida H, Takabayashi A, Sho M, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H, Miyake M (1999) Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 79:1553–1563CrossRefPubMed
go back to reference Janot F, Klijanienko J, Russo A, Mamet JP, de Braud F, El-Naggar AK, Pignon JP, Luboinski B, Cvitkovic E (1996) Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis. Br J Cancer 73:531–538PubMed Janot F, Klijanienko J, Russo A, Mamet JP, de Braud F, El-Naggar AK, Pignon JP, Luboinski B, Cvitkovic E (1996) Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis. Br J Cancer 73:531–538PubMed
go back to reference Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290–298PubMed Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290–298PubMed
go back to reference Kowalski LP, Medina JE (1998) Nodal metastases: predictive factors. Otolaryngol Clin North Am 31:621–637CrossRefPubMed Kowalski LP, Medina JE (1998) Nodal metastases: predictive factors. Otolaryngol Clin North Am 31:621–637CrossRefPubMed
go back to reference Kyzas AP, Stefanou D, Agnantis NJ (2004a) Immunohistochemical expression of vascular endothelial growth factor correlates with positive surgical margins and recurrence in T1 and T2 squamous cell carcinoma (SCC) of the lower lip. Oral Oncol 40:941–947CrossRefPubMed Kyzas AP, Stefanou D, Agnantis NJ (2004a) Immunohistochemical expression of vascular endothelial growth factor correlates with positive surgical margins and recurrence in T1 and T2 squamous cell carcinoma (SCC) of the lower lip. Oral Oncol 40:941–947CrossRefPubMed
go back to reference Kyzas PA, Stefanou D, Agnantis NJ (2005) COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma. Mod Pathol 18:153–160 Kyzas PA, Stefanou D, Agnantis NJ (2005) COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma. Mod Pathol 18:153–160
go back to reference Lalla RV, Boisoneau DS, Spiro JD, Kreutzer DL (2003) Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129:882–888CrossRefPubMed Lalla RV, Boisoneau DS, Spiro JD, Kreutzer DL (2003) Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129:882–888CrossRefPubMed
go back to reference Leedy DA, Trune DR, Kronz JD, Weidner N, Cohen JI (1994) Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma of the tongue. Otolaryngol Head Neck Surg 111:417–422PubMed Leedy DA, Trune DR, Kronz JD, Weidner N, Cohen JI (1994) Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma of the tongue. Otolaryngol Head Neck Surg 111:417–422PubMed
go back to reference Linder S, Blasjo M, von Rosen A, Parrado C, Falkmer UG, Falkmer S (2001) Pattern of distribution and prognostic value of angiogenesis in pancreatic duct carcinoma: a semiquantitative immunohistochemical study of 45 patients. Pancreas 22:240–247CrossRefPubMed Linder S, Blasjo M, von Rosen A, Parrado C, Falkmer UG, Falkmer S (2001) Pattern of distribution and prognostic value of angiogenesis in pancreatic duct carcinoma: a semiquantitative immunohistochemical study of 45 patients. Pancreas 22:240–247CrossRefPubMed
go back to reference Maeda T, Matsumura S, Hiramura H, Jikko A, Furukawa S, Ishida T, Fuchihata H (1998) Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its asspciation with tumour progression and p53 gene status. J Clin Pathol 51:771–775PubMedCrossRef Maeda T, Matsumura S, Hiramura H, Jikko A, Furukawa S, Ishida T, Fuchihata H (1998) Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its asspciation with tumour progression and p53 gene status. J Clin Pathol 51:771–775PubMedCrossRef
go back to reference Meert AP, Paesmans M, Martin B, Delmotte P, Berghmans T, Verdebout JM, Lafitte JJ, Mascaux C, Sculier JP (2002) The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 87:694–701CrossRefPubMed Meert AP, Paesmans M, Martin B, Delmotte P, Berghmans T, Verdebout JM, Lafitte JJ, Mascaux C, Sculier JP (2002) The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 87:694–701CrossRefPubMed
go back to reference Mineta H, Miura K, Ogino T, Satoru T, Misawa K, Ueda Y (2002) Vascular endothelial growth factor (VEGF) expression correlates with p53 and ki-67 expressions in tongue squamous cell carcinoma. Anticancer Res 22:1039–1044PubMed Mineta H, Miura K, Ogino T, Satoru T, Misawa K, Ueda Y (2002) Vascular endothelial growth factor (VEGF) expression correlates with p53 and ki-67 expressions in tongue squamous cell carcinoma. Anticancer Res 22:1039–1044PubMed
go back to reference Moriyama M, Kumagai S, Kawashiri S, Kojima K, Kakihara K, Yamamoto E (1997) Immunohistochemical study of tumor angiogenesis in oral squamous cell carcinoma. Oral Oncol 33:369–374PubMedCrossRef Moriyama M, Kumagai S, Kawashiri S, Kojima K, Kakihara K, Yamamoto E (1997) Immunohistochemical study of tumor angiogenesis in oral squamous cell carcinoma. Oral Oncol 33:369–374PubMedCrossRef
go back to reference Neuchrist C, Quint C, Pammer A, Burian M (1999) Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study. Acta Otolaryngol (Stockh) 119:732–738CrossRef Neuchrist C, Quint C, Pammer A, Burian M (1999) Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study. Acta Otolaryngol (Stockh) 119:732–738CrossRef
go back to reference Neuchrist C, Erovic BM, Handisurya A, Fischer MB, Steiner GE, Hollemann D, Gedlicka C, Saaristo A, Burian M (2003) Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head Neck 25:464–474CrossRefPubMed Neuchrist C, Erovic BM, Handisurya A, Fischer MB, Steiner GE, Hollemann D, Gedlicka C, Saaristo A, Burian M (2003) Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head Neck 25:464–474CrossRefPubMed
go back to reference Pazouki S, Chisholm DM, Adi MM, Carmichael G, Farquharson M, Ogden GR, Schor SL, Schor AM (1997) The association between tumour progression and vascularity in the oral mucosa. J Pathol 183:39–43CrossRefPubMed Pazouki S, Chisholm DM, Adi MM, Carmichael G, Farquharson M, Ogden GR, Schor SL, Schor AM (1997) The association between tumour progression and vascularity in the oral mucosa. J Pathol 183:39–43CrossRefPubMed
go back to reference Penfold CN, Partridge M, Rojas R, Langdon JD (1996) The role of angiogenesis in the spread of oral squamous cell carcinoma. Br J Oral Maxillofac Surg 34:37–41CrossRefPubMed Penfold CN, Partridge M, Rojas R, Langdon JD (1996) The role of angiogenesis in the spread of oral squamous cell carcinoma. Br J Oral Maxillofac Surg 34:37–41CrossRefPubMed
go back to reference Reinmuth N, Parikh AA, Ahmad SA, Liu W, Stoeltzing O, Fan F, Takeda A, Akagi M, Ellis LM (2003) Biology of angiogenesis in tumors of the gastrointestinal tract. Microsc Res Tech 60:199–207CrossRefPubMed Reinmuth N, Parikh AA, Ahmad SA, Liu W, Stoeltzing O, Fan F, Takeda A, Akagi M, Ellis LM (2003) Biology of angiogenesis in tumors of the gastrointestinal tract. Microsc Res Tech 60:199–207CrossRefPubMed
go back to reference Riedel F, Gotte K, Schwalab J, Schafer C, Hormann K (2000) Vascular endothelial growth factor correlates with p53 mutations and angiogenesis in squamous cell carcinoma of the head and neck. Acta Otolaryngol 120:105–111PubMedCrossRef Riedel F, Gotte K, Schwalab J, Schafer C, Hormann K (2000) Vascular endothelial growth factor correlates with p53 mutations and angiogenesis in squamous cell carcinoma of the head and neck. Acta Otolaryngol 120:105–111PubMedCrossRef
go back to reference Salven P, Heikkila P, Anttonen A, Kajanti M, Joesuu H (1997) Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod Pathol 10:1128–1133PubMed Salven P, Heikkila P, Anttonen A, Kajanti M, Joesuu H (1997) Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod Pathol 10:1128–1133PubMed
go back to reference Sawatsubashi M, Yamada T, Fukushima N, Mizokami H, Tokunaga O, Shin T (2000) Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch 436:243–248CrossRefPubMed Sawatsubashi M, Yamada T, Fukushima N, Mizokami H, Tokunaga O, Shin T (2000) Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch 436:243–248CrossRefPubMed
go back to reference Schimming R, Marme D (2002) Endoglin (CD105) expression in squamous cell carcinoma of the oral cavity. Head Neck 24:151–156CrossRefPubMed Schimming R, Marme D (2002) Endoglin (CD105) expression in squamous cell carcinoma of the oral cavity. Head Neck 24:151–156CrossRefPubMed
go back to reference Shpitzer T, Chaimoff M, Gal R, Stern Y, Feinmesser R, Segal K (1996) Tumor angiogenesis as a prognostic factor in early oral tongue cancer. Arch Otolaryngol Head Neck Surg 122:865–868PubMed Shpitzer T, Chaimoff M, Gal R, Stern Y, Feinmesser R, Segal K (1996) Tumor angiogenesis as a prognostic factor in early oral tongue cancer. Arch Otolaryngol Head Neck Surg 122:865–868PubMed
go back to reference Smith BD, Smith GL, Carter D, Sasaki CT, Hafty BG (2000) Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 18:2046–2052PubMed Smith BD, Smith GL, Carter D, Sasaki CT, Hafty BG (2000) Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 18:2046–2052PubMed
go back to reference Tae K, El-Naggar A, Yoo E, Feng L, Lee J, Hong WK, Hittelman WN, Shin DM (2000) Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis. Clin Cancer Res 6:2821–2828PubMed Tae K, El-Naggar A, Yoo E, Feng L, Lee J, Hong WK, Hittelman WN, Shin DM (2000) Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis. Clin Cancer Res 6:2821–2828PubMed
go back to reference Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T (1997) Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 15:826–832PubMed Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T (1997) Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 15:826–832PubMed
go back to reference Underiner TL, Ruggeri B, Gingrich DE (2004) Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy. Curr Med Chem 11:731–745CrossRefPubMed Underiner TL, Ruggeri B, Gingrich DE (2004) Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy. Curr Med Chem 11:731–745CrossRefPubMed
go back to reference Vermeulen PB, Fox SB, Dirix LY, Colpaert C, Van Marck EA (2002a) Heterogeneity of vascularisation in invasive breast carcinoma. Eur J Cancer 38:1951–1952CrossRefPubMed Vermeulen PB, Fox SB, Dirix LY, Colpaert C, Van Marck EA (2002a) Heterogeneity of vascularisation in invasive breast carcinoma. Eur J Cancer 38:1951–1952CrossRefPubMed
go back to reference Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M (2002b) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38:1564–1579CrossRefPubMed Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M (2002b) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38:1564–1579CrossRefPubMed
go back to reference Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1–8PubMedCrossRef Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1–8PubMedCrossRef
go back to reference Williams JK, Carlson GW, Cohen C, Derose PB, Hunter S, Jurkiewicz MJ (1994) Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 168:373–380PubMedCrossRef Williams JK, Carlson GW, Cohen C, Derose PB, Hunter S, Jurkiewicz MJ (1994) Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 168:373–380PubMedCrossRef
go back to reference Xiangming C, Hokita S, Natsugoe S, Tanabe G, Baba M, Takao S, Kuroshima K, Aikou T (1998) Angiogenesis as an unfavorable factor related to lymph node metastasis in early gastric cancer. Ann Surg Oncol 5:585–589PubMedCrossRef Xiangming C, Hokita S, Natsugoe S, Tanabe G, Baba M, Takao S, Kuroshima K, Aikou T (1998) Angiogenesis as an unfavorable factor related to lymph node metastasis in early gastric cancer. Ann Surg Oncol 5:585–589PubMedCrossRef
Metadata
Title
Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma
Authors
Panayiotis A Kyzas
Dimitrios Stefanou
Anna Batistatou
Niki J Agnantis
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 9/2005
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-005-0003-6

Other articles of this Issue 9/2005

Journal of Cancer Research and Clinical Oncology 9/2005 Go to the issue